Form 4: Inmune Bio Director Scott Juda Increases Stake with $36,350 Purchase

Director Scott Juda of Inmune Bio, Inc. [INMB] recently purchased 5,000 shares of common stock at $7.27 per share, increasing his indirect holdings.

Summary

• On June 25, 2024, Scott Juda, a director of Inmune Bio, Inc., acquired 5,000 shares of common stock.
• The purchase price was $7.27 per share.
• The total value of the purchase was $36,350.
• Following the transaction, Juda indirectly owns 71,603 shares through Fossick Capital LP.
• Juda has voting and dispositive control over the shares held by Fossick Capital LP.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by a director is generally viewed positively.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates